These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15608514)

  • 1. DNA methylation and cancer therapy: new developments and expectations.
    Esteller M
    Curr Opin Oncol; 2005 Jan; 17(1):55-60. PubMed ID: 15608514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg.
    Esteller M
    Clin Immunol; 2003 Oct; 109(1):80-8. PubMed ID: 14585279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methyltransferases as targets for cancer therapy.
    Ghoshal K; Bai S
    Drugs Today (Barc); 2007 Jun; 43(6):395-422. PubMed ID: 17612710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of DNA methylation in hematologic malignancies.
    Rush LJ; Plass C
    Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.
    Galm O; Esteller M
    Int J Hematol; 2004 Aug; 80(2):120-7. PubMed ID: 15481439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents.
    Claus R; Almstedt M; Lübbert M
    Semin Oncol; 2005 Oct; 32(5):511-20. PubMed ID: 16210092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of epigenetic changes in hematological malignancies.
    Lehmann U; Brakensiek K; Kreipe H
    Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant DNA methylation as a cancer-inducing mechanism.
    Esteller M
    Annu Rev Pharmacol Toxicol; 2005; 45():629-56. PubMed ID: 15822191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA methylation and cancer--DNA methylation as a target of cancer chemotherapy].
    Miyamoto K; Ushijima T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2021-9. PubMed ID: 14712760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical advances in hypomethylating agents targeting epigenetic pathways.
    Cang S; Lu Q; Ma Y; Liu D
    Curr Cancer Drug Targets; 2010 Aug; 10(5):539-45. PubMed ID: 20384584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of DNA methylation in the management of cancer.
    Esteller M
    Lancet Oncol; 2003 Jun; 4(6):351-8. PubMed ID: 12788407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic gene silencing in cancer: the DNA hypermethylome.
    Esteller M
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R50-9. PubMed ID: 17613547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
    Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
    Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring topology of low-intensity DNA methylation sites for high-throughput assessment of epigenetic drug-induced effects in cancer cells.
    Gertych A; Farkas DL; Tajbakhsh J
    Exp Cell Res; 2010 Nov; 316(19):3150-60. PubMed ID: 20813111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F; Brown R
    J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.